Author Correction: Super enhancers targeting ZBTB16 in osteogenesis protect against osteoporosis

Correction to: Bone Res 10.1038/s41413-023-00267-8, published online 7 June 2023

Following publication of this article,¹ it is noticed that the terms “immortal TERT4-MSCs” and “hFOB1.19 cells” were switched in Fig. 1, Fig. 4 and Supplementary Fig. 1.

The correct Fig. 1 should read:

Fig. 1 SE profile analysis and identification of critical OB-gain SEs. a ChIP-seq profile heatmaps showing H3K27ac abundance in hBMMSCs, H3K27ac and BRD4 abundance in hFOB1.19 cells and H3K27ac and MED1 abundance in immortal TERT4-MSCs. b Example signal traces of OB-gain, OB-lost and nonspecific SEs. The shadows indicate SE regions. c ChIP-seq profile heatmaps of the SEs identified by H3K27ac in hBMMSCs, H3K27ac and BRD4 in hFOB1.19 cells and H3K27ac and MED1 in immortal TERT4-MSCs. d The average SE signal levels are shown in line plots, and the numbers of OB-lost and OB-gain SEs are shown in histograms. e Venn diagram showing the intersecting OB-gain SEs from different datasets. f GO analyses of OB-gain SEs from different datasets

The correct fig. 4 should read:

The correct Supplementary Fig. 1 should read:

The affected texts mentioning the two terms have been corrected in the article.

The original article¹ was updated.